Keyphrases
United States
100%
Cost-effectiveness
100%
Live Attenuated Influenza Vaccine
100%
Inactivated Influenza Vaccine
100%
Trivalent
85%
Trivalent Inactivated Influenza Vaccine
85%
Influenza
28%
Vaccine Effectiveness
28%
Influenza-like Illness
28%
Influenza Vaccine
28%
Clinical Trials
14%
Cost Estimation
14%
Randomized Controlled Trial
14%
Healthy children
14%
Direct Costs
14%
Relative Cost
14%
Health Care Use
14%
Indirect Costs
14%
Cost Savings
14%
Societal Costs
14%
Patient-level Data
14%
Relative Benefit
14%
Direct Medical Costs
14%
Cost Data
14%
Vaccine Cost
14%
Relative Reduction
14%
Acquisition Cost
14%
Quality-adjusted Life Years
14%
Societal Perspective
14%
Advisory Committee on Immunization Practices
14%
Productivity Loss
14%
Probabilistic Sensitivity Analysis
14%
Vaccination Cost
14%
Long Head
14%
Vaccinated children
14%
One-way Sensitivity Analysis
14%
Vaccine Recommendations
14%
Child Loss
14%
Loss of Parent
14%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Influenza Vaccine
100%
Health Care Cost
53%
Vaccine
13%
Disease
13%
Clinical Trial
6%
Health Care
6%
Randomized Controlled Trial
6%
Quality Adjusted Life Year
6%
Pharmacology, Toxicology and Pharmaceutical Science
Live Attenuated Influenza Vaccine
100%
Influenza Vaccine
100%
Vaccine
25%
Disease
25%
Clinical Trial
12%
Randomized Controlled Trial
12%